All Stories

  1. Real-Time PCR Targeting the penA Mosaic XXXIV Type for Prediction of Extended-Spectrum-Cephalosporin Susceptibility in Clinical Neisseria gonorrhoeae Isolates
  2. Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
  3. Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
  4. Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae
  5. Reply to “Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory—a Response from the Front Line”
  6. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis
  7. Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing To PredictmecA-Mediated Oxacillin Resistance in Atypical Staphylococcus aureus
  8. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints
  9. Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory
  10. Performance of Etest for Antimicrobial Susceptibility Testing of Abiotrophia defectiva and Granulicatella Species: TABLE 1
  11. In VitroAntimicrobial Susceptibility of Staphylococcus pseudintermedius Isolates of Human and Animal Origin: TABLE 1
  12. Performance and Verification of a Real-Time PCR Assay Targeting thegyrAGene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae: TABLE 1
  13. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans
  14. Point-Counterpoint: Reflex Cultures Reduce Laboratory Workload and Improve Antimicrobial Stewardship in Patients Suspected of Having Urinary Tract Infections
  15. Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group
  16. Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae
  17. Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica
  18. Superbugs on Duodenoscopes: the Challenge of Cleaning and Disinfection of Reusable Devices
  19. First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
  20. Development of a Novel Real-Time PCR Assay with High-Resolution Melt Analysis To Detect and Differentiate OXA-48-Like β-Lactamases in Carbapenem-Resistant Enterobacteriaceae
  21. In VitroActivity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci
  22. Photo Quiz: A Child with Fever after Hematopoietic Stem Cell Transplantation: FIG 1
  23. Answer to May 2015 Photo Quiz
  24. Comparison of the AmpliVue, BD Max System, andillumigene Molecular Assays for Detection of Group B Streptococcus in Antenatal Screening Specimens
  25. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI Breakpoints
  26. Performance of Etest and Disk Diffusion for Detection of Ciprofloxacin and Levofloxacin Resistance in Salmonella enterica
  27. Laboratory Evaluation of Three Rapid Diagnostic Tests for Dual Detection of HIV and Treponema pallidum Antibodies
  28. Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013
  29. Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and Storage
  30. Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing
  31. In Vitro Antimicrobial Susceptibility of Aerococcus urinae
  32. Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
  33. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile Molecular Assays for Diagnosis of C. difficile Infection
  34. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Staphylococcus spp. and Enterococcus spp.
  35. Detection of Intestinal Protozoa in the Clinical Laboratory
  36. Frequency of Susceptibility Testing for Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
  37. A Current Perspective on Daptomycin for the Clinical Microbiologist
  38. New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae , United States
  39. Emergence of daptomycin-non-susceptible enterococci urinary tract isolates
  40. Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome
  41. Clinical impact of switching conventional enzyme immunoassay with nucleic acid amplification test for suspected Clostridium difficile-associated diarrhea
  42. Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli
  43. Ciprofloxacin-Resistant Aeromonas hydrophila Cellulitis following Leech Therapy
  44. Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity
  45. Rapid Detection of Campylobacter Antigen by Enzyme Immunoassay Leads to Increased Positivity Rates
  46. Use of Rapid Diagnostic Tests for Diagnosis of Malaria in the United States: Table 1
  47. Laboratory Tests for the Diagnosis of Clostridium difficile Infections
  48. The emerging problem of linezolid-resistant Staphylococcus
  49. Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium
  50. In Vitro Susceptibility Testing of Fluoroquinolone Activity Against Salmonella: Recent Changes to CLSI Standards
  51. Should Laboratories Test Methicillin-Resistant Staphylococcus aureus for Elevated Vancomycin Minimum Inhibitory Concentrations by Etest as a Driver of Treatment Changes?
  52. De Novo Daptomycin-Nonsusceptible Enterococcal Infections
  53. Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Los Angeles County
  54. The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in Pediatric Wound Cultures
  55. Case-Control Study ComparingDe Novoand Daptomycin-Exposed Daptomycin-Nonsusceptible Enterococcus Infections
  56. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia
  57. Aerococcus urinae and Trimethoprim-Sulfamethoxazole : Table 1.
  58. Establishing Diagnosis of Haemophilus Parainfluenzae as Etiology of Culture-negative Endocarditis Using DNA Sequence Analysis on Tissue Specimen
  59. Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2
  60. New Delhi Metallo- -Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies
  61. Sticky situation: localized adherence of enteropathogenicEscherichia colito the small intestine epithelium
  62. Enteric Fever in a 6-Year-Old Traveler Caused by Salmonella enterica Serotypes Typhi and Paratyphi A: Laboratory Detection Strategies and Treatment Options
  63. N‐acetyllactosamine‐induced retraction of bundle‐forming pili regulates virulence‐associated gene expression in enteropathogenic Escherichia coli
  64. The Cpx envelope stress response both facilitates and inhibits elaboration of the enteropathogenic Escherichia coli bundle‐forming pilus
  65. A real-time quantitative PCR assay for evaluating Clostridium difficile adherence to differentiated intestinal Caco-2 cells
  66. First Report of Treatment of Anaerobiospirillum succiniciproducens Bloodstream Infection with Levofloxacin
  67. Interactions of Enteropathogenic Escherichia coli with Pediatric and Adult Intestinal Biopsy Specimens during Early Adherence
  68. From alpha to beta: identification of amino acids required for the N‐acetyllactosamine‐specific lectin‐like activity of bundlin
  69. The phosphate transport system of enteropathogenic Escherichia coli is involved in adherence to the host
  70. The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin
  71. N-Acetyllactosamine Conjugated to Gold Nanoparticles Inhibits Enteropathogenic Escherichia coli Colonization of the Epithelium in Human Intestinal Biopsy Specimens
  72. Basis for N-acetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence